12:00 AM
 | 
May 15, 2000
 |  BC Week In Review  |  Company News  |  Deals

Xenogen, DuPont deal

DuPont will evaluate Xenogen's in vivo imaging technology that enables the detection of fluorescent...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >